Trials / Completed
CompletedNCT04622839
Post-Operative Pain Control Following Shoulder Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate overall opioid and non-narcotic analgesic use following surgical treatment for shoulder pathology, and recommend evidence based guidelines for standardized postoperative pain management.
Detailed description
There is currently very limited information in the literature regarding postoperative pain medication consumption following orthopedic shoulder surgery. To fill this knowledge gap, this study will evaluate overall opioid consumption in morphine milligram equivalents following surgical treatment for shoulder pathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tylenol and NSAIDS (Ibuprofen, diclofenac) | This study will assess an aspect of perioperative care relating to pain control. Subjects will not be aware of which aspect is randomized, but will be given a list of possible aspects which will include the intervention (listed below): * Agents used in nerve block (lidocaine vs ropivacaine) * Location of injection for analgesic * Use of over-the-counter pain management (including but not limited to acetaminophen, ibuprofen, naproxen, etc.) * Type of initial opioid prescribed (including but not limited to oxycodone, tramadol, hydrocodone, etc.) * Number of pills in the initial opioid prescription * Instructions for sling wear (duration of use or type of sling) * Ice usage (duration of use and frequency of use) Blinding the participant to the randomized aspect of this study will help prevent bias in patient responses for outcome scores and medication usage. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-07-31
- Completion
- 2022-07-31
- First posted
- 2020-11-10
- Last updated
- 2023-02-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04622839. Inclusion in this directory is not an endorsement.